Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01)

Stopped early · Not applicable · Has a placebo group

Conditions studied: Type 1 Diabetes Mellitus

In brief

The purpose of this study is to assess the long term safety and efficacy in subjects with Type 1 Diabetes Mellitus who completed the Protege Study (CP-MGA031-01).

Key facts

Study ID

NCT00870818

Run by

MacroGenics

People needed

219

Starts

2009-02-01

Expected to finish

2011-05-01

Last updated by the study team

2023-08-09

Who can join

Age: 10 and older, up to 37. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Complete Protocol CP-MGA031-01 (i.e., all subjects who complete Study Day 728, regardless of how many doses of study drug are received).
• Provide written informed consent.

You may not qualify if…

• None

Where it is running

• Atlanta Diabetes Associates — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.